WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held regenerative medicine company, has appointed Michael Lewis, M.D., as Chief Medical Officer and Peter Hamilton as Vice President of Manufacturing and Production. Dr. Lewis and Mr. Hamilton bring to Histogenics significant experience within the medical device and orthopaedics fields. Histogenics is advancing NeoCart®, an autologous bioengineered neocartilage grown outside the body using the patient’s own cells for the repair of full thickness cartilage lesions, and VeriCart™, a cartilage matrix designed, when combined with autologous stem cells, to stimulate cartilage repair in a simple, one-step procedure at the point of damage.
